Response Options to “Histologic Type”
___ Leiomyosarcoma
___ Leiomyosarcoma, epithelioid type
___ Leiomyosarcoma, myxoid type
___ Endometrial stromal sarcoma, low grade#
___ Endometrial stromal sarcoma with smooth muscle differentiation, low grade
___ Endometrial stromal sarcoma with sex cord elements, low grade
___ Endometrial stromal sarcoma with glandular elements, low grade
___ Endometrial stromal sarcoma, high grade
___ Undifferentiated uterine/endometrial sarcoma
___ Adenosarcoma
___ Adenosarcoma with rhabdomyoblastic differentiation
___ Adenosarcoma with cartilaginous differentiation
___ Adenosarcoma with osseous differentiation
___ Adenosarcoma with other heterologous element (specify): _______________________
___ Adenosarcoma with sarcomatous overgrowth
___ Rhabdomyosarcoma
___ Malignant perivascular epithelioid cell tumor
___ Other histologic type not listed (specify): _________________________________
# Low-grade endometrial stromal sarcoma is distinguished from benign endometrial stromal nodule by depth of myometrial invasion ≥3 mm, lymphovascular invasion, or ≥3 foci of myometrial invasion of any depth. Minor marginal irregularity in the form of tongues <3 mm is allowable for an endometrial stromal nodule. This protocol does not apply to endometrial stromal nodules.
Response Options to “Other Tissue/ Organ Involvement” (select all that apply)
Note: Any organ not selected is either not involved or was not submitted.
___ Not applicable
___ Not identified
___ Right ovary
___ Left ovary
___ Ovary (side not specified)
___ Right fallopian tube
___ Left fallopian tube
___ Fallopian tube (side not specified)
___ Vagina
___ Right parametrium
___ Left parametrium
___ Parametrium (side not specified)
___ Pelvic wall
___ Omentum
___ Other organs/tissue (specify): ________________
___ Cannot be determined (explain):_________________________
*Note: Lymph nodes designated as pelvic, parametrial, obturator, internal iliac (hypogastric), external iliac, common iliac, sacral, presacral, and para-aortic are considered regional lymph nodes. Any other involved nodes should be categorized as metastases (pM1) and commented on in the distant metastasis section. Presence of isolated tumor cells no greater than 0.2 mm in regional lymph node(s) is considered N0(i+). Reporting the number of lymph nodes with isolated tumor cells is required only in the absence of metastasis greater than 0.2 mm in other lymph nodes.